RxDoctor Payments Data

Daniel Brown

Podiatrist · Harrisburg, ILNPI 1548374887

Payments from drug & device makers

What this record shows

This record is dominated by other: $131,314 of the $135,745 with a category attached, or 96.7%. Convatec Inc. accounts for 97.2% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $72,260, more than ten times the $169 reported in 2019. Among podiatrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$135,745in general payments, 2019–2025

Across 76 payments — averaging $1786.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$132K
  • Paragon 28, Inc.$1K
  • Treace Medical Concepts, Inc.$784
  • Elite Orthopedics, LLC$671
  • Smith+Nephew$261
  • Paratek Pharmaceuticals, Inc.$199
  • plus $706 from 18 others

What the payments were for

  • Travel & lodging$2,2562%
  • Food & beverage$1,5041%
  • Education$6710%
  • Other$131,31497%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$135,745 in reported general payments places this provider in the 95th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$290,331
Medicare patients
765
Services billed
7,425

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox81$2,072
Ketoconazole60$1,832
Gabapentin84$1,262
Pregabalin14$1,050
Terbinafine Hcl76$824
Clobetasol Propionate17$729
Doxycycline Hyclate76$541
Triamcinolone Acetonide38$318
CiclopiroxCiclopirox Olamine11$162
Allopurinol18$137
Methylprednisolone15$121
Cephalexin16$108
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha12$90
Clindamycin Hcl11$76
Levofloxacin14$40

Paid to pharmacies, not to this prescriber.

Other podiatrist in Harrisburg

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →